The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study
Crossref DOI link: https://doi.org/10.1186/s12886-016-0207-3
Published Online: 2016-03-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arnold, Jennifer J.
Markey, Caroline M.
Kurstjens, Nicol P.
Guymer, Robyn H.
Funding for this research was provided by:
Novartis Pharmaceuticals Australia Pty Ltd